A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
(HealthDay News) — Stockholm3, which combines prostate-specific antigen (PSA), plasma protein biomarkers, polygenic risk, and clinical factors offers greater clinical net benefit for detecting ...
Greater clinical net benefit for Stockholm3, driven by fewer false-negative results. (HealthDay News) — Stockholm3, which combines prostate-specific antigen (PSA), plasma protein biomarkers, polygenic ...
Hosted on MSN
Multivariable risk score beneficial for identifying clinically significant prostate cancer
THURSDAY, June 25, 2026 (HealthDay News) -- Stockholm3, which combines prostate-specific antigen (PSA), plasma protein biomarkers, polygenic risk, and clinical factors offers greater clinical net ...
Sugar-sweetened beverage (SSB) and fruit juice intake is associated with increased risk of hypertension, according to a study published online June 22 in Circul ...
Researchers found that finerenone, compared with placebo, decreases sudden death risk in patients with cardio-kidney-metabolic syndrome.
Elevated interferon levels are independently linked to key metabolic abnormalities in SLE, including dyslipidemia and pancreatic β‑cell dysfunction.
Even after the introduction of ETI for cystic fibrosis, habit continues to have a key role in adherence to inhaled medicines in patients with CF.
BACKGROUND: Sudden cardiac arrest disproportionately affects youths from lower socioeconomic neighborhoods, yet the ...
The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results